Published in Cancer Weekly, July 20th, 2004
According to a study from the United States, "integrins of the alpha(v) family, such as alpha(v)beta(3) and alpha(v)beta(5), are implicated in tumor-induced angiogenesis; but their role in tumor growth has not been fully explored. CNTO 95 is a fully human antibody that recognizes the alpha(v) family of integrins and is likely to be less immunogenic in humans compared to chimeric or humanized antibodies."
"CNTO 95 bound to purified alpha(v)beta(3) and alpha(v)beta(5) with a K-d of approximately 200 pM and to alpha(v) integrin-expressing human cells with a K-d of 1-24 nM. In vitro, CNTO 95...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.